By Larry Storer The U.S. Centers for Medicare and Medicaid Services have published the final fee schedule for new Current Procedural Terminology (CPT) Category 1 codes for BTG International’s Varithena procedures, and changed CPT codes for Medtronic’s VenaSeal, effective Jan. 1, 2018. The new codes for Varithena, which close veins
Market research analysts at Technavio predict that the global inferior vena cava (IVC) filter market will grow steadily during the next four years and post a CAGR of more than 11 percent by 2021. This market research analysis identifies the preference for minimally invasive procedures with improved medical imaging as
California-based ManaMed has launched the U.S. Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device PlasmaFlow in the United States. The portable, tubeless and digital PlasmaFlow, which comes with multiple pressure functions, helps to prevent the onset of DVT in patients by revitalizing blood flow in the
As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In a study published in a recent issue of JACC: Cardiovascular